Scientists at USC Michelson Center for Convergent Bioscience and Japan’s Nagoya University find and test a promising drug that stops cancer by interfering with the cancer cells’ metabolism and other circadian-related functions
A new drug shows potential to halt cancer cells’ growth by stunting the cells’ biological clock.
The findings from scientists at the USC Michelson Center for Convergent Bioscience and Nagoya University’s Institute of Transformative BioMolecules (ITbM) advance a burgeoning area of research: turning the body’s circadian rhythms against cancer.
Their study, conducted on human kidney cancer cells and on acute myeloid leukemia in mice, was published Jan. 23 in the journal Science Advances.
Scientists know that disrupting sleep and other elements of humans’ circadian rhythm can harm health. The same is true for the circadian clock of cells themselves. If researchers could disturb the circadian clock of cancer cells, they theorize, they could potentially hurt or kill those cells.
The scientists found that a molecule named GO289 targets an enzyme that controls the cell’s circadian rhythm. This drug-protein interaction then disrupts the functions of four other proteins that are important for cell growth and survival.
Human bone cancer cells stopped growing when a drug molecule jammed their circadian rhythm during a study that appears in Science Advances. Photo courtesy of the Kay lab at the USC Michelson Center for Convergent Bioscience.
In effect, GO289 can jam the cogs of the cell’s circadian clock, slowing its cycles. And it can do so with little impact to healthy cells.
“In some cancers, the disease takes over the circadian clock mechanism and uses it for the evil purpose of helping itself grow,” said Steve Kay, director of convergent biosciences at the USC Michelson Center and USC Provost Professor of Neurology, Biomedical Engineering and Biological Sciences. “With GO289, we can interfere with those processes and stop the cancer from growing.”
Kay is among several scientists from USC Dornsife College of Letters, Arts and Sciences, USC Viterbi School of Engineering and Keck School of Medicine of USC who are collaborating across multiple disciplines to find new solutions for treating cancer, neurological disease and cardiovascular disease.
Finding the right candidate
On its initial interactions with human bone cancer cells, GO289 appeared to slow the tumors’ circadian clock as it targeted an enzyme, named CK2.
To see if GO289 consistently hindered other cancers in the same way, the scientists then tested it on human kidney cancer cells and on mice with acute myeloid leukemia. They found that GO289 specifically affected cancer cell metabolism and other circadian-related functions that normally would enable the cancer to grow and spread.
Kay is optimistic about the findings. “This could become an effective new weapon that kills cancer,” he said.
The Latest on: Cancer
via Google News
The Latest on: Cancer
- Mickey Thomas: 'I'm cancer free' says ex-Wales midfielder on May 23, 2019 at 12:36 pm
Former Wales winger Mickey Thomas says he is cancer free following an operation. The 64-year-old was diagnosed with stomach cancer in January and began treatment soon after. In a social media post, ... […]
- Function of liver cancer genes in mini-organs on May 23, 2019 at 11:56 am
Researchers have developed a human model in which they use organoids, or mini organs, to study the function of specific genes that are mutated in liver cancer. Using this method, they have found that ... […]
- Black men not at higher risk of dying from prostate cancer, study finds on May 23, 2019 at 10:09 am
The new study debunks the myth that genetics plays a larger role than health disparities in risk of death from prostate cancer for black men. Breaking News Emails SUBSCRIBE By Shamard Charles, M.D. ... […]
- Scotland Reports a Drop in Risk of Cancer on May 23, 2019 at 10:04 am
The risk of developing cancer in Scotland fell by nearly 4% from 2008 to 2017, according to a new report. (Getty Stock Images) A recently released report from the Scottish government offers some good ... […]
- Cancer Docs Need Help Pushing Healthy Habits on Obese Patients on May 23, 2019 at 10:01 am
Most oncologists routinely assess a patient's body-mass index (BMI) and physical activity level in the course of treatment, but are less likely to assess a patient's diet or make referrals to support ... […]
- Prostate Cancer Kills More Black Men Than White Men on May 23, 2019 at 9:23 am
Black men are twice as likely to die of prostate cancer than white men – and the disparity is largely driven by who has access to high-quality treatment, a new study indicates. An analysis of more ... […]
- AI Beats Radiologists for Accuracy in Lung Cancer Screening on May 23, 2019 at 8:42 am
Lung cancer screening using low-dose computed tomography (LDCT) is now recommended for certain populations, and while it has been shown to reduce mortality, there are persistent challenges with this ... […]
- Studying the function of liver cancer genes in mini-organs on May 23, 2019 at 8:04 am
Researchers from the Hubrecht Institute and Radboud University have developed a human model in which they use organoids, or mini organs, to study the function of specific genes that are mutated in ... […]
- 7 dietary factors may increase your risk of cancer: Study on May 23, 2019 at 6:03 am
Seven dietary factors may increase the risk of cancer for American adults aged 20 and over, according to a new study published in the JNCI Cancer Spectrum medical journal. The study, conducted by ... […]
- These 5 dietary factors may increase your risk of cancer, study finds on May 23, 2019 at 5:40 am
Dr. Jennifer Ashton discusses what to know about a new study that links a diet low in whole grains, among other factors, to an increased risk of cancer. ... […]
via Bing News